Literature DB >> 25663347

Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.

Ahmet Ozer1, Cengiz Z Altuntas2, Fuat Bicer3, Kenan Izgi3, Scott J Hultgren4, Guiming Liu2, Firouz Daneshgari5.   

Abstract

Diabetic patients have increased susceptibility to infections, and urinary tract infections (UTI) are the most common type in women with diabetes mellitus. Knowledge of bacterial clearance effectiveness following UTI in diabetics is sparse. In this study, the effects of diabetes on bacterial clearance efficiency and components of the innate immune system in response to UTI in a murine model were investigated. Streptozotocin-induced diabetic and control female C57BL/6J mice were infected with uropathogenic Escherichia coli, and bacterial load, expression of chemokines, and neutrophil infiltration in the bladder over time were investigated. Expression levels of histone deacetylases were also measured to address a potential mechanism underlying the phenotype. Bacterial clearance during UTI was significantly prolonged in diabetic mice relative to controls. Neutrophil infiltration in bladder tissue and urine, and both mRNA and protein expression of chemokines MIP-2, KC, MCP-1 and IL-6 in bladder tissue were diminished at early time points after infection in diabetic mice relative to controls. In addition, mRNA levels of histone deacetylases 1-5 were increased in diabetic mice. This is the first study to show an association of impaired bacterial clearance in diabetic mice with suppression of UTI-induced chemokine expression and neutrophil infiltration in the bladder. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ELISA; myeloperoxidase; quantitative real-time RT-PCR; type 1 fimbria

Mesh:

Substances:

Year:  2015        PMID: 25663347      PMCID: PMC4443837          DOI: 10.1093/femspd/ftv002

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  58 in total

1.  Gender-specific role of HDAC11 in kidney ischemia- and reperfusion-induced PAI-1 expression and injury.

Authors:  Jee In Kim; Kyong-Jin Jung; Hee-Seong Jang; Kwon Moo Park
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-08

2.  Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.

Authors:  J J Martinez; M A Mulvey; J D Schilling; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

3.  Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells.

Authors:  M Hedlund; B Frendéus; C Wachtler; L Hang; H Fischer; C Svanborg
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

4.  Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.

Authors:  M A Mulvey; J D Schilling; S J Hultgren
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.

Authors:  Benjamin L Duell; Alison J Carey; Chee K Tan; Xiangqin Cui; Richard I Webb; Makrina Totsika; Mark A Schembri; Petra Derrington; Helen Irving-Rodgers; Andrew J Brooks; Allan W Cripps; Michael Crowley; Glen C Ulett
Journal:  J Immunol       Date:  2011-12-19       Impact factor: 5.422

6.  Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy.

Authors:  Xiaojie Wang; Jiang Liu; Junhui Zhen; Chun Zhang; Qiang Wan; Guangyi Liu; Xinbing Wei; Yan Zhang; Ziying Wang; Huirong Han; Huiyan Xu; Chanchan Bao; Zhenyu Song; Xiumei Zhang; Ningjun Li; Fan Yi
Journal:  Kidney Int       Date:  2014-04-09       Impact factor: 10.612

7.  Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.

Authors:  J D Schilling; M A Mulvey; C D Vincent; R G Lorenz; S J Hultgren
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Lysine-specific demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) synergistically repress proinflammatory cytokines and classical complement pathway components.

Authors:  Andreas Janzer; Soyoung Lim; Florian Fronhoffs; Naima Niazy; Reinhard Buettner; Jutta Kirfel
Journal:  Biochem Biophys Res Commun       Date:  2012-04-17       Impact factor: 3.575

Review 9.  Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms.

Authors:  Robert V Intine; Michael P Sarras
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

10.  G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.

Authors:  Molly A Ingersoll; Kimberly A Kline; Hailyn V Nielsen; Scott J Hultgren
Journal:  Cell Microbiol       Date:  2008-08-26       Impact factor: 3.715

View more
  10 in total

1.  Hyperglucosuria induced by dapagliflozin augments bacterial colonization in the murine urinary tract.

Authors:  Panatda Saenkham; Jamie Jennings-Gee; Braden Hanson; Nancy D Kock; L Garry Adams; Sargurunathan Subashchandrabose
Journal:  Diabetes Obes Metab       Date:  2020-05-18       Impact factor: 6.577

2.  Copper Is a Host Effector Mobilized to Urine during Urinary Tract Infection To Impair Bacterial Colonization.

Authors:  Amanda N Hyre; Kylie Kavanagh; Nancy D Kock; George L Donati; Sargurunathan Subashchandrabose
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

3.  Vaginal Inoculation of Uropathogenic Escherichia coli during Estrus Leads to Genital and Renal Colonization.

Authors:  Christen K Robinson; Panatda Saenkham-Huntsinger; Braden S Hanson; L Garry Adams; Sargurunathan Subashchandrabose
Journal:  Infect Immun       Date:  2022-03-31       Impact factor: 3.609

Review 4.  Systematic Review of Literature Examining Bacterial Urinary Tract Infections in Diabetes.

Authors:  Santosh Paudel; Preeti P John; Seyedeh Leila Poorbaghi; Tara M Randis; Ritwij Kulkarni
Journal:  J Diabetes Res       Date:  2022-05-17       Impact factor: 4.061

5.  Glycosuria Alters Uropathogenic Escherichia coli Global Gene Expression and Virulence.

Authors:  Md Jahirul Islam; Kamal Bagale; Preeti P John; Zachary Kurtz; Ritwij Kulkarni
Journal:  mSphere       Date:  2022-04-28       Impact factor: 5.029

6.  Activation of NLRP3 by uropathogenic Escherichia coli is associated with IL-1β release and regulation of antimicrobial properties in human neutrophils.

Authors:  Isak Demirel; Alexander Persson; Annelie Brauner; Eva Särndahl; Robert Kruse; Katarina Persson
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

7.  HIF-1 mediated activation of antimicrobial peptide LL-37 in type 2 diabetic patients.

Authors:  Soumitra Mohanty; Witchuda Kamolvit; Silvia Zambrana; Eduardo Gonzales; Jonas Tovi; Kerstin Brismar; Claes-Göran Östenson; Annelie Brauner
Journal:  J Mol Med (Berl)       Date:  2021-10-15       Impact factor: 4.599

8.  Isolation of Skin Leukocytes Uncovers Phagocyte Inflammatory Responses During Induction and Resolution of Cutaneous Inflammation in Fish.

Authors:  Amro M Soliman; Taekwan Yoon; Jiahui Wang; James L Stafford; Daniel R Barreda
Journal:  Front Immunol       Date:  2021-09-24       Impact factor: 7.561

9.  Diabetes downregulates the antimicrobial peptide psoriasin and increases E. coli burden in the urinary bladder.

Authors:  Soumitra Mohanty; Witchuda Kamolvit; Andrea Scheffschick; Anneli Björklund; Jonas Tovi; Alexander Espinosa; Kerstin Brismar; Thomas Nyström; Jens M Schröder; Claes-Göran Östenson; Pontus Aspenström; Hanna Brauner; Annelie Brauner
Journal:  Nat Commun       Date:  2022-09-20       Impact factor: 17.694

Review 10.  A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity.

Authors:  Rebecca Dowey; Ahmed Iqbal; Simon R Heller; Ian Sabroe; Lynne R Prince
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.